Demand High for New Drug That Offers Flu Vaccine Without Needle Injection, According to SG Cowen Survey


NEW YORK -- According to a survey conducted by SG Cowen, there is strong demand among doctors for FluMist, a flu vaccine that is administered through the nose rather than by a shot in the arm. The survey also concludes that patients would overwhelmingly prefer the intranasal vaccine.

Confirming that patients don't like shots, the survey found that 78 percent of patients would prefer an intranasal vaccine versus an intramuscular vaccine, and that physicians would use FluMist in over 50 percent of flu vaccinations.

The FluMist survey results were released today at the firm's conference on Therapeutic Categories in New York. Additional key FluMist survey findings include:

* 90 percent of physicians would prescribe a live attenuated intranasal vaccine such as FluMist instead of the traditional inactivated intramuscular flu vaccine.

* Pricing is a key issue; the survey suggests most patients will not pay more than $20 for FluMist

* Demand for FluMist will exceed supply for the first couple of seasons

FluMist is being developed by MedImmune and is expected to generate 60 percent of MedImmune's (MEDI) 2003-2006 revenue growth, according to SG Cowen.

"Based on the results of our survey, we believe that FluMist is poised for a successful launch," says Phil Nadeau, a senior biotech analyst at SG Cowen.

SG Cowen is the U.S.-based investment banking division of SG, the corporate and investment banking arm of Societe Generale, and is a leader in producing comprehensive surveys of key issues and trends in the healthcare field.

Source: PRNewswire

Related Videos
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
COVID-19 germs, fungi, bacteria objects. (Adobe Stock 584704860 by chawalit)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Related Content